Delivery of High-Quality Biomarker Assays

por Swanson, Brian N.
Publicado 2002

Acceptance of online education in China: A reassessment in light of changed circumstances due to the COVID-19 pandemic

por Swanson, Brian A., Valdois, Ahneka
Publicado 2022

Validity of Fitbit’s active minutes as compared with a research-grade accelerometer and self-reported measures

por Brewer, Wayne, Swanson, Brian T, Ortiz, Alexis
Publicado 2017

“Trustworthiness,” confidence in estimated effects, and confidently translating research into clinical practice

por Riley, Sean P., Swanson, Brian T., Cook, Chad E.
Publicado 2023

A pilot study to determine the effect of one physical therapy session on physical activity levels for individuals with chronic low back pain

por Brewer, Wayne, Swanson, Brian T., Roddey, Toni S., Adewale, Habeeblai, Ashmore, Caleb, Frerich, Jennifer, Perrin, Cory, Ortiz, Alexis
Publicado 2017

Evaluation of Potential Disease‐Mediated Drug–Drug Interaction in Patients With Moderate‐to‐Severe Atopic Dermatitis Receiving Dupilumab

por Davis, John D., Bansal, Ashish, Hassman, David, Akinlade, Bolanle, Li, Meng, Li, Zhaoyang, Swanson, Brian, Hamilton, Jennifer D., DiCioccio, A. Thomas
Publicado 2018

Poster 1023: Dupilumab suppresses Th2 inflammation in adult asthma and atopic dermatitis

por Swanson, Brian, Ming, Jeffrey, Ren, Haobo, Wang, Lin, Wenzel, Sally, Beck, Lisa, Diciccio, Thomas, Li, Yongtao, Belomestnov, Pavel, Graham, Neil, Pirozzi, Gianluca, Hamilton, Jennifer
Publicado 2014

Effect of Dupilumab on Type 2 Biomarkers in Chronic Rhinosinusitis With Nasal Polyps: SINUS-52 Study Results

por Bachert, Claus, Laidlaw, Tanya M., Cho, Seong H., Mullol, Joaquim, Swanson, Brian N., Naimi, Souad, Classe, Marion, Harel, Sivan, Jagerschmidt, Alexandre, Laws, Elizabeth, Ruddy, Marcella, Praestgaard, Amy, Amin, Nikhil, Mannent, Leda P.
Publicado 2023

Dupilumab reduces local type 2 pro‐inflammatory biomarkers in chronic rhinosinusitis with nasal polyposis

por Jonstam, Karin, Swanson, Brian N., Mannent, Leda P., Cardell, Lars‐Olaf, Tian, Nian, Wang, Ying, Zhang, Donghui, Fan, Chunpeng, Holtappels, Gabriele, Hamilton, Jennifer D., Grabher, Annette, Graham, Neil M. H., Pirozzi, Gianluca, Bachert, Claus
Publicado 2019

Dupilumab suppresses type 2 inflammatory biomarkers across multiple atopic, allergic diseases

por Hamilton, Jennifer D., Harel, Sivan, Swanson, Brian N., Brian, William, Chen, Zhen, Rice, Megan S., Amin, Nikhil, Ardeleanu, Marius, Radin, Allen, Shumel, Brad, Ruddy, Marcella, Patel, Naimish, Pirozzi, Gianluca, Mannent, Leda, Graham, Neil M. H.
Publicado 2021

Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Dupilumab in Healthy Adult Subjects

por Li, Zhaoyang, Radin, Allen, Li, Meng, Hamilton, Jennifer D., Kajiwara, Miyuki, Davis, John D., Takahashi, Yoshinori, Hasegawa, Setsuo, Ming, Jeffrey E., DiCioccio, A. Thomas, Li, Yongtao, Kovalenko, Pavel, Lu, Qiang, Ortemann‐Renon, Catherine, Ardeleanu, Marius, Swanson, Brian N.
Publicado 2020

Effects of PCSK9 Inhibition With Alirocumab on Lipoprotein Metabolism in Healthy Humans

por Reyes-Soffer, Gissette, Pavlyha, Marianna, Ngai, Colleen, Thomas, Tiffany, Holleran, Stephen, Ramakrishnan, Rajasekhar, Karmally, Wahida, Nandakumar, Renu, Fontanez, Nelson, Obunike, Joseph, Marcovina, Santica M., Lichtenstein, Alice H., Matthan, Nirupa R., Matta, James, Maroccia, Magali, Becue, Frederic, Poitiers, Franck, Swanson, Brian, Cowan, Lisa, Sasiela, William J., Surks, Howard K., Ginsberg, Henry N.
Publicado 2017